An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...
Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...
The U.S. Food and Drug Administration approved treatment for 11 patients with the rare familial ALS caused by mutations in ...
An American neurologist and an Italian epidemiologist whose work revolutionised the treatment of multiple sclerosis yesterday ...
Statin use does not affect survival outcomes for ALS patients, so there may be no need to stop taking them after a diagnosis, ...
A patient who sustained aphasia due to amyotrophic lateral sclerosis has regained the ability to communicate after receiving ...
To address this challenge, 14 patients with sporadic ALS ... role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosis, Journal of Neuroinflammation (2025).